Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Viveve Medical, Inc. VIVE
$0.05
-$0.01 (-11.09%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
570511.00000000
-
week52high
1.20
-
week52low
0.03
-
Revenue
6426000
-
P/E TTM
0
-
Beta
0.23529400
-
EPS
-2.64000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Mizuho | Underperform | Buy | 25 ноя 2020 г. |
| Maxim Group | Hold | Buy | 25 ноя 2020 г. |
| Ladenburg Thalmann | Neutral | Buy | 25 ноя 2020 г. |
| Ladenburg Thalmann | Buy | Neutral | 03 дек 2019 г. |
| Ladenburg Thalmann | Neutral | Buy | 24 июл 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Robbins Jim B | A | 57000 | 57000 | 03 янв 2023 г. |
| Presnell Sharon Collins | A | 36000 | 36000 | 03 янв 2023 г. |
| Morris Arlene | A | 36000 | 36000 | 03 янв 2023 г. |
| JORN DEBORA | A | 36000 | 36000 | 03 янв 2023 г. |
| Durbin Scott | A | 360000 | 360000 | 03 янв 2023 г. |
| Basta Steven L | A | 72000 | 72000 | 03 янв 2023 г. |
| Durbin Scott | A | 258000 | 258000 | 04 янв 2022 г. |
| Basta Steven L | A | 48000 | 48000 | 04 янв 2022 г. |
| Robbins Jim B | A | 42000 | 42000 | 04 янв 2022 г. |
| Presnell Sharon Collins | A | 18000 | 18000 | 04 янв 2022 г. |
Новостная лента
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
InvestorPlace
17 янв 2023 г. в 08:43
Viveve Medical (NASDAQ: VIVE ) stock is falling hard on Tuesday after releasing results from the company's latest clinical trial. That trial covers the use of the Viveve treatment for women suffering from stress urinary incontinence.
Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript
Seeking Alpha
10 ноя 2022 г. в 21:25
Viveve Medical, Inc. (NASDAQ:VIVE ) Q3 2022 Results Conference Call November 10, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Scott Durbin - CEO Jim Robbins - SVP, Finance and Administration Operator Good afternoon. Welcome to the Viveve Third Quarter 2022 Financial Results and Corporate Update Conference Call.
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
Accesswire
27 окт 2022 г. в 08:28
ENGLEWOOD, CO / ACCESSWIRE / October 27, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its third quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 10, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
11 авг 2022 г. в 18:38
Viveve Medical, Inc. (NASDAQ:VIVE ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - SVP, Finance and Administration Scott Durbin - CEO Conference Call Participants Operator Good afternoon, and welcome to the Viveve Second Quarter 2022 Financial Results and Corporate Update Conference Call. [Operator Instructions] Please note, this event is being recorded.
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
Accesswire
28 июл 2022 г. в 16:28
ENGLEWOOD, CO / ACCESSWIRE / July 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its second quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 11, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.